GSK-205820

Study Sponsor: GSK

Study Title

A Two Part Study to Assess i) the Relative Bioavailability and Food Effect of a Novel Tablet Formulation of Boosted-GSK2838232 Compared to Capsule and ii) the Safety and Pharmacokinetics of Repeated Once-Daily Doses of Non-boosted GSK2838232

Medicine or Vaccine (generic name)

GSK2838232

Sponsor Identification Number

205820

Trial Registry Identification Number(#'s)

NCT03234036

Medical Condition

Infection, Human Immunodeficiency Virus

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205820

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03234036

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. This study is available in CDISC format.

Date Added to this Site

July 2020